Clinical Trial

Probiotics in Obesity Management

Completed
View on ClinicalTrials.gov →
Summary
Evaluate the effects of pasteurized Akkermansia muciniphila Akk11 (killed bacteria) capsules compared to placebo on body composition parameters (including weight, BMI, body fat percentage, waist - hip ratio (WHR), wrist circumference, visceral fat area, and basal metabolic rate) and blood lipid levels (total cholesterol (TC), low - density lipoprotein (LDL), high - density lipoprotein (HDL), and triglycerides (TG)) in overweight or obese adults.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-07.
Status change: Recruiting → Completed 2026-01-27
Trial Details
NCT Number NCT06964932
Lead Sponsor Wecare Probiotics Co., Ltd.
Conditions Obesity
Enrollment 61 participants
Start Date 2025-03-15
Primary Completion 2025-12-03 (estimated)
Study Completion 2026-01-28 (estimated)
Updated on ClinicalTrials.gov 2026-01-29